Drug that delays type 1 diabetes from developing is approved in the US

Teplizumab, as compared to a placebo, delayed the onset of type 1 diabetes in both children and adults by over three years in an ongoing experiment. The US has approved the use of a novel medication that may postpone type 1 diabetes in youngsters by up to three years. The medication, teplizumab, is expected to … Read more